DS
ABBV icon

DRW Securities’s AbbVie ABBV Stock Holding History

DRW Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$293K Buy
+1,353
New +$300K ﹤0.01% 909
2025
Q4 		– Sell
-6,516
Closed -$1.5M – 1197
2025
Q3 		$1.5M Sell
6,516
-22,677
-78% -$4.62M 0.03% 305
2025
Q2 		$5.38M Sell
29,193
-9,623
-25% -$1.79M 0.12% 96
2025
Q1 		$8.13M Buy
38,816
+34,324
+764% +$6.67M 0.23% 61
2024
Q4 		$798K Buy
+4,492
New +$826K 0.03% 253
2024
Q3 		– Sell
-5,125
Closed -$878K – 546
2024
Q2 		$878K Sell
5,125
-5,891
-53% -$976K 0.03% 259
2024
Q1 		$2M Buy
11,016
+9,346
+560% +$1.61M 0.05% 120
2023
Q4 		$259K Sell
1,670
-2,044
-55% -$298K ﹤0.01% 255
2023
Q3 		$554K Sell
3,714
-1,663
-31% -$244K 0.01% 203
2023
Q2 		$724K Sell
5,377
-1,831
-25% -$269K 0.02% 179
2023
Q1 		$1.15M Buy
+7,208
New +$1.1M 0.02% 129
2022
Q4 		– Sell
-5,288
Closed -$710K – 254
2022
Q3 		$710K Buy
5,288
+2,830
+115% +$406K 0.02% 132
2022
Q2 		$376K Sell
2,458
-5,756
-70% -$880K 0.01% 174
2022
Q1 		$1.33M Buy
8,214
+3,603
+78% +$523K 0.04% 115
2021
Q4 		$624K Buy
4,611
+2,749
+148% +$325K 0.02% 124
2021
Q3 		$201K Sell
1,862
-4,485
-71% -$512K 0.01% 233
2021
Q2 		$715K Buy
+6,347
New +$715K 0.02% 151
2020
Q2 		– Sell
-68,302
Closed -$5.2M – 168
2020
Q1 		$5.2M Buy
+68,302
New +$5.82M 0.19% 38
2018
Q1 		– Sell
-22,344
Closed -$2.16M – 166
2017
Q4 		$2.16M Buy
+22,344
New +$2.11M 0.23% 62
2016
Q2 		– Sell
-10,000
Closed -$571K – 75
2016
Q1 		$571K Buy
+10,000
New +$557K 0.03% 47

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DRW Securities's ABBV Position: Q1 2026 in Review

DRW Securities opened a new position in AbbVie (ABBV) in Q1 2026: 1,353 shares worth $293K. The stake represents ﹤0.01% of the portfolio and ranks #909 among its holdings. This is a return to the name: DRW Securities previously reported a position in ABBV as recently as Q3 2025.

DRW Securities first reported a position in ABBV in Q1 2016 and has held it in 20 quarters since. The position peaked at $8.13M in Q1 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • DRW Securities held 1,353 shares of AbbVie worth $293K as of Q1 2026.
  • AbbVie was a new DRW Securities position in Q1 2026.
  • AbbVie made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #909 holding.
  • DRW Securities first reported a position in AbbVie in Q1 2016 and has held it in 20 quarters since.
  • DRW Securities's AbbVie position peaked at $8.13M in Q1 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.